Landos Biopharma, Inc. announced a private placement of 30,909,090 shares at an issue price of $0.54 per share for the gross proceeds of $16,690,908.6 on January 4, 2023. The transaction will include participation from returning investor Perceptive Advisors LLC, largest shareholder in the company. The closing of the financing is subject to customary closing conditions and is expected to close on or before January 10, 2023.